2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B1225S
    Promazine-d6 hydrochloride
    Promazine-d6 (hydrochloride) (Romtiazin-d6 (hydrochloride)) is deuterium labeled Promazine (hydrochloride). Promazine (Romtiazin) hydrochloride is an antipsychotic and a dopamine receptor D2 antagonist. Promazine hydrochloride inhibits dopaminergic neurotransmission.
    Promazine-d<sub>6</sub> hydrochloride
  • HY-130547S
    BS2G Crosslinker-d4 disodium
    BS2G Crosslinker-d4 disodium is the deuterium labeled BS2G Crosslinker disodium (HY-130547). BS2G Crosslinker is an amine-reactive homobifunctional protein crosslinker. BS2G Crosslinker enables stable protein-protein, peptide, and biomolecule conjugation.
    BS2G Crosslinker-d<sub>4</sub> disodium
  • HY-10285S2
    Saxagliptin-13C2
    Saxagliptin-13C2 (BMS-477118-13C2) is 13C labeled Saxagliptin. Saxagliptin (BMS-477118) is a potent, selective, reversible, competitive and orally active dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) inhibitor. Saxagliptin has the peotential for type 2 diabetes mellitus research.
    Saxagliptin-<sup>13</sup>C<sub>2</sub>
  • HY-W783639S
    Bzo-poxizid-d9
    Bzo-poxizid-d9 (5C-MDA-19-d9, Petyl MDA-19-d9) is deuterium labeled Bzo-poxizid. Bzo-poxizid is a synthetic cannabinoid that is a psychoactive substance.
    Bzo-poxizid-d<sub>9</sub>
  • HY-W032022S2
    1-Hexanol-d3
    		99.05%
    1-Hexanol-d3 is the deuterium labeled 1-Hexanol. 1-Hexanol, a primary alcohol, is a surfactant that can be employed in industrial processes to enhance interfacial properties. 1-Hexanol uncouples mitochondrial respiration by a non-protonophoric mechanism.
    1-Hexanol-d<sub>3</sub>
  • HY-W103935S
    2,2-Bis(((2-cyano-3,3-diphenylacryloyl)oxy)methyl)propane-1,3-diyl bis(2-cyano-3,3-diphenylacrylate)-d40
    2,2-Bis(((2-cyano-3,3-diphenylacryloyl)oxy)methyl)propane-1,3-diyl bis(2-cyano-3,3-diphenylacrylate)-d40 (Uvinul 3030-d40) is deuterium labeled 2,2-Bis(((2-cyano-3,3-diphenylacryloyl)oxy)methyl)propane-1,3-diyl bis(2-cyano-3,3-diphenylacrylate).
    2,2-Bis(((2-cyano-3,3-diphenylacryloyl)oxy)methyl)propane-1,3-diyl bis(2-cyano-3,3-diphenylacrylate)-d<sub>40</sub>
  • HY-B0690S
    Fosinopril-d5
    Fosinopril-d5 (SQ28555-d5 (free acid)) is deuterium labeled Fosinopril. Fosinopril (SQ28555 free acid) is the ester proagent of angiotensin-converting enzyme (ACE) inhibitor with an IC50 value of 0.18 μM. Fosinopril demonstrates a non-competitive inhibition effect on ACE activity with an Ki value of 1.675 μM.
    Fosinopril-d<sub>5</sub>
  • HY-W011885S
    1-Dodecylpyrrolidin-2-one-d6
    1-Dodecylpyrrolidin-2-one-d6 (N-Lauryl-2-pyrrolidone-d6) is deuterium-labeled 1-Dodecylpyrrolidin-2-one (HY-W011885).
    1-Dodecylpyrrolidin-2-one-d<sub>6</sub>
  • HY-165661S
    Oleic acid-hydroxy Oleoyl Leucine-d7
    Oleic acid-hydroxy Oleoyl Leucine-d7 is deuterium labeled Oleic acid-hydroxy Oleoyl Leucine.
    Oleic acid-hydroxy Oleoyl Leucine-d<sub>7</sub>
  • HY-176362S
    4-F-Benzenesulfonate-pyrrole(2-F-Ph)-methylamine-d3
    4-F-Benzenesulfonate-pyrrole(2-F-Ph)-methylamine-d3 is the deuterium labeled 4-F-Benzenesulfonate-pyrrole(2-F-Ph)-methylamine.
    4-F-Benzenesulfonate-pyrrole(2-F-Ph)-methylamine-d3
  • HY-131106S
    Clorprenaline-d7
    Clorprenaline-d7 is a deuterium labeled Clorprenaline. Clorprenaline is a β2-adrenergic receptor agonist that is implicated in bronchial expansion. Clorprenaline has the potential for asthma research.
    Clorprenaline-d<sub>7</sub>
  • HY-W088178S
    N,N-Dimethylbenzenesulfonamide-d2
    N,N-Dimethylbenzenesulfonamide-d2 is the deuterium labeled N,N-Dimethylbenzenesulfonamide (HY-W088178).
    N,N-Dimethylbenzenesulfonamide-d<sub>2</sub>
  • HY-152065S
    3,7-Dimethyloct-6-en-1-ol-d2
    6-Octen-1,1-d2-1-ol, 3,7-dimethyl- is deuterated labeled 6-Octen-1,1-1-ol, 3,7-dimethyl-.
    3,7-Dimethyloct-6-en-1-ol-d<sub>2</sub>
  • HY-111095S3A
    D-(-)-Lactic acid-13C-2 sodium
    D-(-)-Lactic acid-13C-2 (sodium) is a 13C-labeled D-(-)-Lactic acid (HY-111095). D-(-)-Lactic acid can be used for a variety of biochemical studies.
    D-(-)-Lactic acid-<sup>13</sup>C-2 sodium
  • HY-113016S1
    Elaidic acid-d17
    Elaidic acid-d17 is deuterium labeled Elaidic acid. Elaidic acid is the major trans fat found in hydrogenated vegetable oils and can be used as a pharmaceutical solvent.
    Elaidic acid-d<sub>17</sub>
  • HY-141911S
    Tauroursodeoxycholic acid-3-sulfate-d4 sodium
    Tauroursodeoxycholic Acid-3-Sulfate Sodium Salt-d4 is the deuterium labeled Tauroursodeoxycholic Acid-3-Sulfate Sodium Salt.
    Tauroursodeoxycholic acid-3-sulfate-d4 sodium
  • HY-W703540
    Deracoxib-d4
    Deracoxib-d4 (SC 046-d4; SC 59046--d4) is deuterium labeled Deracoxib (HY-17509). Deracoxib, an orally active COX-2 inhibitor, is a veterinary nonsteroidal anti-inflammatory agent used exclusively in dogs. Deracoxib inhibits the COX-2 enzyme to reduce the production of prostaglandins, effectively controlling pain and inflammation after canine soft tissue surgery. Deracoxib reduces the inhibition of COX-1 and lowers the risk of gastrointestinal side effects. Deracoxib induces tumor cell cycle arrest and apoptosis, and shows anti-tumor activity in canine osteosarcoma, breast tumors and bladder transitional cell carcinomas.
    Deracoxib-d<sub>4</sub>
  • HY-W718034
    1,2-Didecanoyl-3-chloropropanediol-d5
    1,2-Didecanoyl-3-chloropropanediol-d5 is deuterium labeled 1,2-Didecanoyl-3-chloropropanediol. 1,2-Didecanoyl-3-chloropropanediol is an ester product.
    1,2-Didecanoyl-3-chloropropanediol-d<sub>5</sub>
  • HY-146915S
    17:0-17:1-17:0 TG-d5
    		99.90%
    17:0-17:1-17:0 TG-d5 is deuterium labeled 17:0-17:1-17:0 TG.
    17:0-17:1-17:0 TG-d<sub>5</sub>
  • HY-W748343
    2,2',5,5'-Tetrachloro-1,1'-biphenyl-13C12
    2,2',5,5'-Tetrachloro-1,1'-biphenyl-13C12 is 13C labeled 2,2',5,5'-Tetrachloro-1,1'-biphenyl.
    2,2',5,5'-Tetrachloro-1,1'-biphenyl-<sup>13</sup>C<sub>12</sub>